After The Ring Study: DREAM

A fact sheet about DREAM (Dapivirine Ring Extended Access and Monitoring), an open-label extension study that provided monthly dapivirine rings for one year to women who had participated in The Ring Study, provides information on the purpose, design, and results of the study.

Length: 
1 page
Year: 
2019
Organization: 
International Partnership for Microbicides
Languages: 
English